Clinical Trials Logo

Smoking Cessation clinical trials

View clinical trials related to Smoking Cessation.

Filter by:

NCT ID: NCT06236347 Enrolling by invitation - Smoking Cessation Clinical Trials

Rural COPD E-Visit Study

Start date: March 19, 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate an electronic visit (e-visit) for COPD screening and for quitting smoking. Participants will be randomly assigned to receive either the smoking cessation e-visit or not. The e-visit will look similar to an online questionnaire asking about smoking history, preferences for cessation medications, and chronic COPD symptoms. Participants may receive a prescription for a smoking cessation medication as an outcome of the e-visit, if randomized to the e-visit group, but there is no requirement to take any medication. This study consists of questionnaires and breath samples provided at 4 separate time points throughout the study. Participation in this study will take about 24 weeks.

NCT ID: NCT06234475 Not yet recruiting - Smoking Cessation Clinical Trials

Smoking Cessation Program for the Elderly

Start date: February 2024
Phase: N/A
Study type: Interventional

This study aims to assess the effect of mobile health (mHealth) support or financial incentives and their interactive intervention effect on smoking cessation (SC) in old smokers in Hong Kong (HK).

NCT ID: NCT06228976 Recruiting - Smoking Cessation Clinical Trials

Mindfulness-based, Mobile Health (mHealth) Smoking Cessation Intervention in Vietnam

Start date: August 27, 2023
Phase: N/A
Study type: Interventional

The goals of this a three-arm randomized controlled trial (RCT) is to evaluate the efficacy of mindfulness-based, culturally appropriate, and mobile phone-based smoking cessation intervention among Vietnamese adult male smokers. The intervention will be delivered via text messages, involving 1,200 adult male smokers, with 400 participants in each of three intervention arms (Cessation Intervention - culturally-adapted smoking cessation messages that incorporate mindfulness; Education Intervention - messages that solely focus on health risks of smoking; Control - basic messages that solely focus on general healthy lifestyle). The investigator will assess cessation rates up to 6-month follow-up, as well as secondary outcomes of knowledge of smoking health risks; stages of change; quit attempts; self-efficacy; cigarettes per day; and nicotine dependence. The investigators hypothesize that participants in the Cessation Intervention group (who will receive culturally-adapted messages) will have higher rates of smoking abstinence, greater knowledge of the health risks of smoking, more transitions from pre-contemplation/contemplation stages to planning/action stages, higher likelihood of making a quit attempt, higher self-efficacy for abstaining from smoking, greater reductions in cigarette consumption, and lower nicotine dependence, compared to participants in the Education Intervention group and Control group.

NCT ID: NCT06218823 Enrolling by invitation - Cancer Clinical Trials

Tobacco Treatment Comparison for Cancer Care

Start date: March 1, 2024
Phase: Phase 4
Study type: Interventional

This pilot comparative effectiveness trial will compare two active smoking cessation treatments in terms of effectiveness, equity across patient subpopulations, and efficiency among adult patients diagnosed with cancer within the past 3 years. An enhanced treatment comprising 12 weeks of varenicline treatment and 7 smoking cessation coaching calls with a cancer focus will be compared against an active comparator modeled after standard quitline treatments (2 weeks of nicotine patch therapy with 3 phone coaching calls). Approximately 50 participants will be recruited to generate estimates of the effects, acceptability, costs, and equity of enhanced treatment (vs. standard treatment), with the primary outcome being abstinence from smoking 26 weeks after trying to quit.

NCT ID: NCT06213532 Not yet recruiting - Smoking Cessation Clinical Trials

CONNECTing to LungCare

Start date: June 30, 2024
Phase: N/A
Study type: Interventional

This study evaluates a smoking cessation intervention (CONNECTing to LungCare) for improving shared decision-making conversations about smoking cessation and lung cancer screening between patients and providers. Shared decision making is a patient care model in which providers offer information regarding risks and benefits, patients express their values and preferences, and then healthcare decisions are jointly discussed between the patient and provider. Patient education, aided by decision support tools, can increase patients' knowledge, decrease their decisional conflict, promote decision making, and improve the patients' perception of risk. CONNECTing to LungCare is an interactive education intervention that addresses lung cancer screening and smoking cessation and provides participants with a tailored summary that may make them more likely to have shared decision-making discussions with their providers about smoking cessation and lung cancer screening.

NCT ID: NCT06187142 Not yet recruiting - Smoking Cessation Clinical Trials

Mobile Phone-Based Smoking-Cessation Intervention for Chronic Patients

Start date: January 1, 2024
Phase: N/A
Study type: Interventional

The study aims to facilitate mobile phone-based cessation support for chronic patients using a sequential multiple assignment randomized trial (SMART) , and combines different effective treatments to enhance engagement and determine the most effective adaptive interventions.

NCT ID: NCT06148909 Not yet recruiting - Smoking Cessation Clinical Trials

Small Talk Intervention With MI for Smoking Cessation

Start date: December 1, 2023
Phase: N/A
Study type: Interventional

The goal of this pilot study is to examine the effectiveness of the STMI in promoting abstinence in unmotivated smokers. The main questions it aims to answer are: - Do unmotivated smokers treated with STMI exhibit higher abstinence rate than those in the control group? - Do unmotivated smokers treated with STMI show higher intention to quit than those in the control group? - Do unmotivated smokers treated with STMI show higher smoking reduction rates than those in the control group? - Do unmotivated smokers treated with STMI show lower level of depressive symptoms than those in the control group? - Do unmotivated smokers treated with STMI show higher adherence than those in the control group? - Does STMI show higher consent rates than those the control? - How does STMI affect the smoking behaviors in unmotivated smokers? Participants will be randomized to (1) STMI or (2) control group for smoking cessation services via telephone, and then be invited to join a semi-structured interview.

NCT ID: NCT06145685 Completed - Smoking Cessation Clinical Trials

Effect of Smoking Cessation on Salivary IL-1β and PGE-2 Levels Following Non-Surgical Periodontal Therapy

Start date: January 1, 2021
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the effect of smoking cessation on inflammatory markers following non-surgical treatment of periodontal disease. This is to assess the period of smoking abstinence needed before any periodontal surgery in order to reverse the negative effects of the reported increased levels of inflammatory markers (IL-1β and PGE2 in this study) associated with smoking on the healing and the periodontium.

NCT ID: NCT06130423 Recruiting - Smoking Cessation Clinical Trials

Study to Evaluate Music Therapy and Nicotine Replacement Therapy on Craving Related to Smoking Cessation in Health Staff

MUSMOKHEALTH
Start date: February 28, 2024
Phase: N/A
Study type: Interventional

The study is a randomized, controlled trial comparing music therapy associated to NRT versus NRT alone to evaluate the value of music therapy in improving the management of craving among 50 health staff smokers. This pilot multi-method study will combine the methodology of clinical trial with qualitative techniques used in social sciences to show the interest of a digital music therapy tool, adapted to a health staff audience.

NCT ID: NCT06127589 Not yet recruiting - Smoking Cessation Clinical Trials

The "Quit-for-Kids" Project: to Increase Abstinence and Protect Children From Tobacco Smoke Exposure

Start date: November 2023
Phase: N/A
Study type: Interventional

This project aims to test the effectiveness of an integrated intervention of brief cessation advice (AWARD), Nicotine Replacement Therapy, and Instant Messaging support compared with waitlist control participants among adult daily smokers who lived with their children and non-smoking partners.